Overview

A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

Status:
Recruiting

Trial end date:
2026-11-01

Target enrollment:

Participant gender:

Summary

A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

Phase:

Early Phase 1

Details

Lead Sponsor:

Zhejiang University